Acelyrin has announced new data from its Phase 2 clinical trial of lonigutamab and revealed the desi...

Sling Therapeutics has revealed positive topline efficacy and safety results from the Phase 2b/3 LID...

Verana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite...

China has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...

HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...

Innovent Biologics announced that its NDA for their recombinant anti-insulin-like growth factor 1 re...

The USC Roski Eye Institute is making significant strides in the realm of Thyroid Eye Disease (TED) ...

Research indicates that most patients with thyroid eye disease (TED) treated with teprotumumab did n...

Viridian Therapeutics has announced positive topline results from the Phase 3 THRIVE-2 clinical tria...